Sandip I. Patel

Insider Reports History

Location
Tampa, FL
Signature
/s/ Abizer Gaslightwala, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sandip I. Patel:

Company Role Class Num Shares Value Price $ Report Date Ownership
AtlasClear Holdings, Inc. Director Common Stock 243,194 $1,128,420 $4.64 09 Feb 2024 Direct
Akari Therapeutics Plc Director American Depositary Shares representing Ordinary Shares 451,857 $506,080 $1.12 20 Mar 2025 Direct
Akari Therapeutics Plc Director Pre-Funded Warrants to purchase ADRs 154,664 $62,499 $0.4041 16 Dec 2025 Direct
Akari Therapeutics Plc Director Series A Warrants (Right to Buy) 44,642 $49,999 $1.12 06 Mar 2025 Direct
Akari Therapeutics Plc Director Series B Warrants (Right to Buy) 44,642 $49,999 $1.12 06 Mar 2025 Direct
Akari Therapeutics Plc Director American Depositary Shares representing Ordinary Shares 20,219 $22,645 $1.12 25 Apr 2025 Davis Island Ventures LLC
Akari Therapeutics Plc Director American Depositary Shares representing Ordinary Shares 19,880 $22,266 $1.12 25 Apr 2025 Quest Bio LLC
Akari Therapeutics Plc Director American Depositary Shares representing Ordinary Shares 13,901 $15,569 $1.12 20 Mar 2025 Innovative Lifesci Investment LLC
Akari Therapeutics Plc Director American Depositary Shares representing Ordinary Shares 6,250 $7,000 $1.12 25 Apr 2025 TT Insurance Investment LLC
Peak Bio, Inc. Director Common Stock 0 $0 $0.2650 14 Nov 2024 Direct
Peak Bio, Inc. Director Common Stock 0 $0 $0.2650 14 Nov 2024 Indirect
Monterey Innovation Acquisition Corp Director, 10%+ Owner Common Stock 1,417,500 09 Mar 2023 Indirect
AtlasClear Holdings, Inc. Director Warrants 354,088 20 Mar 2024 Direct
Akari Therapeutics Plc Director Warrants to purchase American Depositary Shares ("ADRs") 247,462 16 Dec 2025 Direct
Akari Therapeutics Plc Director Stock Option (Right to Buy) 225,000 20 Mar 2025 Direct
Akari Therapeutics Plc Director Warrants to purchase ADRs 154,664 16 Dec 2025 Direct
Monterey Innovation Acquisition Corp Director, 10%+ Owner Common Stock 35,000 09 Mar 2023 Direct
Akari Therapeutics Plc Director American Depositary Shares representing Ordinary Shares 13,901 25 Apr 2025 Innovative Lifesci Investments LLC
Peak Bio, Inc. Director Convertible Notes 0 14 Nov 2024 Direct
Peak Bio, Inc. Director Stock Option (Right to Buy) 0 14 Nov 2024 Direct
Quantum FinTech Acquisition Corp Director Common Stock 0 09 Feb 2024 Direct

Insider Reports Filed by Sandip I. Patel

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AKTX Akari Therapeutics Plc 16 Dec 2025 4 +$162,499 4 Director 18 Dec 2025, 21:57
AKTX Akari Therapeutics Plc 25 Apr 2025 3 +$149,997 4 Director 29 Apr 2025, 17:00
AKTX Akari Therapeutics Plc 20 Mar 2025 2 $0 4 Director 24 Mar 2025, 17:00
AKTX Akari Therapeutics Plc 14 Nov 2024 0 $0 3 Director 22 Nov 2024, 16:30
/report/000095017024128153-patel-sandip-i-2024-11-14 Peak Bio, Inc. 14 Nov 2024 7 -$275,500 4 Director 18 Nov 2024, 18:55
ATCH AtlasClear Holdings, Inc. 09 Feb 2024 2 $0 4 Director 16 Apr 2024, 17:26
ATCH AtlasClear Holdings, Inc. 09 Feb 2024 0 $0 3 Director 16 Apr 2024, 17:24
/report/000147450624000043-patel-sandip-i-2024-02-09 Quantum FinTech Acquisition Corp 09 Feb 2024 1 $0 4 Director 16 Feb 2024, 19:13
/report/000110465923031926-patel-sandip-i-2023-03-09 Monterey Innovation Acquisition Corp 09 Mar 2023 2 -$3,420 4 Director, 10%+ Owner 13 Mar 2023, 20:44
/report/000110465921121336-patel-sandip-i-2021-09-30 Monterey Bio Acquisition Corp 30 Sep 2021 0 $0 3 Director, 10%+ Owner 30 Sep 2021, 17:51